In vitro release and in vivo anti-tumor efficacy of doxorubicin from biodegradable temperature-sensitive star-shaped PLGA-PEG block copolymer hydrogel

34Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Doxorubicin (DXR) was loaded into two kinds of thermo-responsive biodegradable star-shaped block copolymer (4arm PLGA-PEG) solutions with different PLGA block lengths under various conditions (drug-concentrations, polymer-concentrations and block compositions). All release profiles of DXR from star-block copolymer hydrogels showed sustained patterns. To assess this polymer as a sustained drug-delivery formulation, in vivo anti-tumor efficacy was examined by using tumor-bearing mice treated with DXR-loaded/ DXR-free hydrogels based on the result of the release study. After 1 month, the mice treated with DXR-loaded S11-C1 and DXR-loaded S9-C1 copolymer solutions had remarkably suppressed tumorvolume compared to that of the mice treated with DXR-free copolymer solution. And DXR-loaded S11 hydrogel showed more significant tumor inhibition due to the different hydrophobicity between S9 and S11 copolymers. In vitro release and in vivo anti-tumor activity studies performed for 1 month revealed the potential of this hydrogel as a sustained and long-term drug delivery carrier. © 2008 The Society of Polymer Science,.

Cite

CITATION STYLE

APA

Lee, S. J., Bae, Y., Kataoka, K., Kim, D., Lee, D. S., & Kim, S. C. (2008). In vitro release and in vivo anti-tumor efficacy of doxorubicin from biodegradable temperature-sensitive star-shaped PLGA-PEG block copolymer hydrogel. Polymer Journal, 40(2), 171–176. https://doi.org/10.1295/polymj.PJ2007179

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free